Related Experiment Video
Updated: May 23, 2025

07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.5K
Rethinking the Evolutionary Origin, Function, and Treatment of Cancer.
1N. N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478, Russia. alicht@mail.ru.
Biochemistry. Biokhimiia
|March 9, 2025
Summary
Cancer is a systemic disease, not just a cellular one. A holistic approach reveals its role in gene pool selection and suggests targeting the cancer interactome for novel treatments.
Area of Science:
- Oncology
- Systems Biology
- Evolutionary Biology
Background:
- Current oncology research often focuses narrowly on intracellular processes, neglecting cancer's systemic nature.
- This reductionist approach limits understanding and therapeutic outcomes.
- A balanced perspective integrating reductionism and holism is necessary.
Purpose of the Study:
- To re-evaluate cancer from a systemic and evolutionary perspective.
- To explore the concept of cancer as a 'special organ' with a function in gene pool purification.
- To investigate the cancer interactome and its role in metastasis and lethality.
Main Methods:
- Holistic systems approach
- Analysis of cancer as an evolutionary mechanism
- Exploration of the cancer interactome
- Review of hereditary and sporadic cancer correlations
Main Results:
- Cancer can be viewed as a mechanism for purifying the gene pool.
- The cancer interactome plays a crucial role in metastasis and lethal outcomes.
- A correlation exists between hereditary and sporadic cancer.
- Cancer's systemic nature is critical for understanding its progression.
Conclusions:
- A shift towards a holistic view is essential for advancing cancer research and treatment.
- Targeting the cancer interactome presents a promising novel therapeutic strategy.
- Understanding cancer's evolutionary role may unlock new insights into its prevention and management.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
What is Cancer?
10.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.4K
Cancer
47.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

